Survivin as prognostic factor in squamous cell carcinoma of the oral cavity

Cancer Letters

Volumn 225, Issue 1, 2005, Pages 27-33

  Lo Muzio, Lorenzo ^a   Farina, Antonio ^b   Rubini, Corrado ^c   Pezzetti, Furio ^b   Stabellini, Giordano ^d   Laino, Gregorio ^e   Santarelli, Andrea ^a   Pannone, Giuseppe ^a   Bufo, Pantaleo ^a   De Lillo, Alfredo ^a   Carinci, Francesco ^f  

^a UNIVERSITY OF FOGGIA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e SECOND UNIVERSITY OF NAPLES   (Italy)

^f UNIVERSITY OF FERRARA   (Italy)

Author keywords

Cancer; Cox analysis; Oral squamous cell carcinoma; Survival; Survivin

Indexed keywords

FLUOROURACIL; SURVIVIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CALCULATION; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MOUTH CARCINOMA; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REGRESSION ANALYSIS; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; PHENOTYPE; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 21144443492     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.11.024     Document Type: Article

References (36)

1. C. Adida, D. Berrebi, M. Peuchmaur, M. Reyes-Mugica, and D.C. Altieri Anti-apoptosis gene, survivin, and prognosis of neuroblastoma Lancet 351 1998 882 883
2. C. Adida, P.L. Crotty, J. McGrath, D. Berrebi, J. Diebold, and D.C. Altieri Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation Am. J. Pathol. 152 1998 43 49
3. D.C. Altieri Validating survivin as a cancer therapeutic target Nat. Rev. Cancer 3 2003 46 54
4. G. Ambrosini, C. Adida, and D.C. Altieri A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma Nat. Med. 3 1997 917 921
5. G. Ambrosini, C. Adida, G. Sirugo, and D.C. Altieri Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting J. Biol. Chem. 273 1998 11177 11182
6. M. Chawla-Sarkar, S.I. Bae, F.J. Reu, B.S. Jacobs, D.J. Lindner, and E.C. Borden Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis Cell Death Differ. 2004
7. C. Chiodino, A.M. Cesinaro, D. Ottani, F. Fantini, A. Giannetti, G.P. Trentini, and C. Pincelli Communication: expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin J. Invest. Dermatol. 113 1999 415 418
8. N.E. Crook, R.J. Clem, and L.K. Miller An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif J. Virol. 67 1993 2168 2174
9. B. Dawson-Saunders, and R.G. Trapp Basic & Clinical Biostatistic 1994 Appleton & Lange Norwalk
10. Q.L. Deveraux, R. Takahashi, G.S. Salvesen, and J.C. Reed X-linked IAP is a direct inhibitor of cell-death proteases Nature 388 1997 300 304
11. Q.L. Deveraux, and J.C. Reed IAP family proteins - suppressors of apoptosis Genes Dev. 13 1999 239 252
12. G.V. Glinsky, V.V. Glinsky, A.B. Ivanova, and C.J. Hueser Apoptosis and metastasis: increased apoptosis resistance of metastatic cancer cells is associated with the profound deficiency of apoptosis execution mechanisms Cancer Lett. 115 1997 185 193
13. D.R. Green, and J.C. Reed Mitochondria and apoptosis Science 281 1998 1309 1312
14. A. Gross, J.M. McDonnell, and S.J. Korsmeyer BCL-2 family members and the mitochondria in apoptosis Genes Dev. 13 1999 1899 1911
15. D. Grossman, J.M. McNiff, F. Li, and D.C. Altieri Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line Lab. Invest. 79 1999 1121 1126
16. D. Grossman, J.M. McNiff, F. Li, and D.C. Altieri Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma J. Invest. Dermatol. 113 1999 1076 1081
17. D. Grossman, P.J. Kim, O.P. Blanc-Brude, D.E. Brash, S. Tognin, P.C. Marchisio, and D.C. Altieri Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53 J. Clin. Invest. 108 2001 991 999
18. M.O. Hengartner The biochemistry of apoptosis Nature 407 2000 770 776
19. D. Hockenbery, G. Nunez, C. Milliman, R.D. Schreiber, and S.J. Korsmeyer Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death Nature 348 1990 334 336
20. M. Holciki, C. Yeh, R.G. Korneluk, and T. Chow Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increases resistance to radiation induced cell death Oncogene 19 2000 4174 4177
21. International Union Against Cancer TNM Classification of Malignant Tumours 2000 Wiley-Liss New York
22. J.L. Jameson Principles of Molecular Medicine 1998 Humana Press Totowa, New Jersey
23. H. Kawasaki, D.C. Altieri, C.D. Lu, M. Toyoda, T. Tenjo, and N. Tanigawa Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer Cancer Res. 58 1998 5071 5074
24. E.C. LaCasse, S. Baird, R.G. Korneluk, and A.E. MacKenzie The inhibitors of apoptosis (IAPs) and their emerging role in cancer Oncogene 17 1998 3247 3259
25. F. Li, G. Ambrosini, E.Y. Chu, J. Plescia, S. Tognin, P.C. Marchisio, and D.C. Altieri Control of apoptosis and mitotic spindle checkpoint by survivin Nature 396 1998 580 584
26. F. Li, E.J. Ackermann, C.F. Bennett, A.L. Rothermel, J. Plescia, S. Tognin, and A. Villa Pleiotropic cell-division defects and apoptosis induced by interference with survivin function Nat. Cell Biol. 1 1999 461 466
27. L. Lo Muzio, G. Pannone, S. Staibano, M.D. Mignogna, C. Rubini, and M.A. Mariggio Survivin expression in oral squamous cell carcinoma Br. J. Cancer 89 2003 2244 2248
28. M. Monzo, R. Rosell, E. Felip, J. Astudillo, J.J. Sanchez, and J. Maestre A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers J. Clin. Oncol. 17 1999 2100
29. G.S. Salvesen, and C.S. Duckett IAP proteins blocking the road to death's door Nat. Rev. Mol. Cell Biol. 3 2002 401 410
30. A.I. Sarela, R.C. Macadam, S.M. Farmery, A.F. Markham, and P.J. Guillou Expression of the antiapoptosis gene. Survivin, predicts death from recurrent colorectal carcinoma Gut 46 2000 645 650
31. H. Sasaki, Y. Sheng, F. Kotsuji, and B.K. Tsang Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells Cancer Res. 60 2000 5659 5666
32. S.S. Sternberg Histology for Pathologist 1997 Lippincott-Raven Publishers Philadelphia
33. H.S. Swana, D. Grossman, J.N. Anthony, R.M. Weiss, and D.C. Altieri Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer N. Engl. J. Med. 341 1999 452 453
34. I. Tamm, Y. Wang, E. Sausville, D.A. Scudiero, N. Vigna, T. Oltersdorf, and J.C. Reed IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95). Bax, caspases, and anticancer drugs Cancer Res. 58 1998 5315 5320
35. K. Tanaka, S. Iwamoto, G. Gon, T. Nohara, M. Iwamoto, and N. Tanigawa Expression of survivin and its relationship to loss of apoptosis in breast carcinomas Clin. Cancer Res. 6 2000 127 134
36. Y. Yang, S. Fang, J.P. Jensen, A.M. Weissman, and J.D. Ashwell Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli Science 288 2000 874 877